Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Acta Neurologica|August 1, 1994
Nicardipine versus propranolol in essential tumorF J Jiménez-Jiménez, P J Garcia-Ruiz, F Cabrera-ValdiviaRevista De Neurologia|January 12, 2018
[Amimia in Parkinson's disease. Significance and correlation with the clinical features]P J Garcia-Ruiz, C E Feliz-Feliz, T Maycas-Cepeda, et al.Journal of the Neurological Sciences|September 27, 2008
Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tauP Navarro, R Guerrero, E Gallego, et al.Clinical Neuropharmacology|February 22, 2000
Bradykinesia in Huntington's diseaseP J Garcia Ruiz, E Gomez Tortosa, V Sanchez Bernados, et al.Archivos De Neurobiologia|September 1, 1990
[Clinical and epidemiologic characteristics of familial Parkinson disease]B Morales, R Astarloa, R González Maldonado, et al.Genetic Counseling (Geneva, Switzerland)|October 24, 2000
A MELAS phenotype and a paternal inherited inversion of chromosome 10 in a female patientI Lorda-Sanchez, P J Garcia-Ruiz, M Rodriguez de Alba, et al.Neurologia|August 4, 2018
Spanish expert consensus on the use of safinamide in Parkinson's diseaseF Valldeoriola, F Grandas, J M Arbelo, et al.Revista De Neurologia|May 13, 2017
[Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy]J C Martinez-Castrillo, J L Pena-Segura, P Sanz-Cartagena, et al.Neurologia|November 9, 2021
Spanish expert consensus on the use of safinamide in Parkinson's diseaseF Valldeoriola, F Grandas, J M Arbelo, et al.Revista De Neurologia|September 28, 2007
[Guide to the comprehensive treatment of spasticity]F Vivancos-Matellano, S I Pascual-Pascual, J Nardi-Vilardaga, et al.Pageof 2